MedPath

Paclisun 300

Brand Name: Paclisun 300

Generic Name: Paclitaxel

Active
Registration Number

DR-XY46655

Dosage Form

Concentrate Solution for IV Infusion (albumin-free Concentrate for Nanodispersion)

Issuance Date

July 31, 2024

Expiry Date

November 9, 2026

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength300 mg/2.73 mL
Packaging5mL-capacity USP Type I colourless tubular glass vial with grey bromobutyl rubber stopper and golden red aluminum flip-off seal (Box of 1's)

Classification

C
Classification
Prescription Drug (Rx)
P
Pharmacologic
Antineoplastic
A
Application
Monitored Release (Reconstruction)
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

PaclitaxelActive
Monograph: Paclitaxel

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform